Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon‐Like Peptide 1 Receptor Agonists

Abstract Objective Glucagon‐like peptide 1 receptor agonists (GLP‐1RA) have shown remarkable results in glycemic control for patients with type 2 diabetes (T2DM). While no association has been made, there is a concern for thyroid cancer (TC) from GLP‐1RA. We aimed to study the 5‐year risk of TC in T...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bao Y. Sciscent, Hanel W. Eberly, F. Jeffrey Lorenz, David Goldrich, Neerav Goyal, David Goldenberg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-01-01
coleção:	OTO Open
Assuntos:	glucagon‐like peptide 1 receptor agonists GLP‐1 thyroid cancer
Acesso em linha:	https://doi.org/10.1002/oto2.70188
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!